Citadel Advisors’s Interpace Biosciences, Inc. Common Stock IDXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-11,858
| Closed | -$37K | – | 5933 |
|
|
2020
Q3 | $37K | Buy |
+11,858
| New | +$37K | ﹤0.01% | 4441 |
|
|
2019
Q2 | – | Sell |
-3,262
| Closed | -$26K | – | 5356 |
|
|
2019
Q1 | $26K | Buy |
+3,262
| New | +$26K | ﹤0.01% | 4371 |
|
|
2018
Q3 | – | Sell |
-2,618
| Closed | -$23K | – | 4946 |
|
|
2018
Q2 | $23K | Buy |
+2,618
| New | +$23K | ﹤0.01% | 4022 |
|
|
2018
Q1 | – | Sell |
-1,928
| Closed | -$20K | – | 4621 |
|
|
2017
Q4 | $20K | Buy |
1,928
+43
| +2% | +$446 | ﹤0.01% | 3769 |
|
|
2017
Q3 | $29K | Buy |
+1,885
| New | +$29K | ﹤0.01% | 3471 |
|
|
2016
Q4 | – | Sell |
-1,086
| Closed | -$17K | – | 4335 |
|
|
2016
Q3 | $17K | Buy |
1,086
+603
| +125% | +$9.44K | ﹤0.01% | 3470 |
|
|
2016
Q2 | $16K | Buy |
+483
| New | +$16K | ﹤0.01% | 3261 |
|
|
2013
Q3 | – | Sell |
-144
| Closed | -$68K | – | 3123 |
|
|
2013
Q2 | $68K | Buy |
+144
| New | +$68K | ﹤0.01% | 2498 |
|